Table 4.
Summary of studies on risk factors and prognostic factors for liposarcoma patients with distant metastases
| Author | Publication Year | Type of Tumor | Numbers of Patients | Risk Factors | Survival Times | Prognostic Factors |
|---|---|---|---|---|---|---|
| Tirumani [9] | 2015 | DDLPS | 44/148 (metastases/total) | tumor grade | 28 months (median, with metastases) | - |
| local recurrence | 38 months (median, without metastases) | |||||
| Muratori [19] | 2018 | MLPS | 36/307 (metastases/total) | surgical margins | - | - |
| PLPS | tumor size | |||||
| DDLPS | local recurrence | |||||
| Muratori [12] | 2018 | MLPS | 20/148 (metastases/total) | type of presentation | - | - |
| tumor grade | ||||||
| surgical margins | ||||||
| local recurrence | ||||||
| Vos [10] | 2018 | All types | 57/441 (metastases/total) | tumor subtypes | - | - |
| Langmans [20] | 2019 | DDLPS | 100 (inoperable or metastatic) | - | 13 months (median OS) | metastasectomy response to first-line chemotherapy |
| MLPS | ||||||
| PLPS |
Abbreviations: DDLPS, dedifferentiated liposarcoma; MLPS, myxoid/round cell liposarcoma; PLPS, pleomorphic liposarcoma.